ACADIA Pharmaceuticals Inc. vs Dicks Sporting Goods Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B). The key difference: Dicks Sporting Goods Inc is far larger — about 3.6× ACADIA Pharmaceuticals Inc.'s market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | DKS | |
|---|---|---|
Market Cap | $5.07B | $18.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.41 | $239.17 |
52-Week Low | $20.06 | $187.78 |
Enterprise Value | $4.19B | $25.14B |
Dividend Yield | — | 2.44% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →